CUSIP No. | 007586100 |
1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). | |
Covington Health Group, LLC | ||
45-2041708 |
2. | Check the Appropriate Box if a Member of a Group (See Instructions) |
(a) | ............................................................................................................................................................................................ | ü | |
(b) | ............................................................................................................................................................................................ | £ |
3. | SEC Use Only ................................................................................................................................................................... |
4. | Source of Funds (See Instructions).............................................................................................................................. | WC |
5. | Check if Disclosure or Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e).......................................... | £ |
6. | Citizenship or Place of Organization ............................................................................................................................. | DE |
7. | Sole Voting Power | -0- | ||
Number of | ||||
Shares | 209,500 | |||
Beneficially | 8. | Shared Voting Power | ||
Owned by | ||||
Each | ||||
Reporting | 9. | Sole Dispositive Power | -0- | |
Person | ||||
With | 10. | Shared Dispositive Power | 209,500 | |
11. | Aggregate Amount Beneficially Owned by Each Reporting Person........................................................................ | 209,500 |
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)................................... | o |
13. | Percent of Class Represented by Amount in Row (11)............................................................................................... | 3.6%** |
14. | Type of Reporting Person (See Instructions) | OO |
CUSIP No. | 007586100 |
1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). | |
John E. McMullan |
2. | Check the Appropriate Box if a Member of a Group (See Instructions) |
(a) | ............................................................................................................................................................................................ | ü | |
(b) | ............................................................................................................................................................................................ | £ |
3. | SEC Use Only ................................................................................................................................................................... |
4. | Source of Funds (See Instructions).............................................................................................................................. | PF |
5. | Check if Disclosure or Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e).......................................... | £ |
6. | Citizenship or Place of Organization.............................................................................................................................. | United States |
7. | Sole Voting Power | 117,160 | ||
Number of | ||||
Shares | 209,500 | |||
Beneficially | 8. | Shared Voting Power | ||
Owned by | ||||
Each | ||||
Reporting | 9. | Sole Dispositive Power | 117,160 | |
Person | ||||
With | 10. | Shared Dispositive Power | 209,500 | |
11. | Aggregate Amount Beneficially Owned by Each Reporting Person........................................................................ | 326,660* |
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)................................... | o |
13. | Percent of Class Represented by Amount in Row (11)............................................................................................... | 5.6%** |
14. | Type of Reporting Person (See Instructions) | IN |
CUSIP No. | 007586100 |
1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). | |
John F. McMullan |
2. | Check the Appropriate Box if a Member of a Group (See Instructions) |
(a) | ............................................................................................................................................................................................ | ü | |
(b) | ............................................................................................................................................................................................ | £ |
3. | SEC Use Only ................................................................................................................................................................... |
4. | Source of Funds (See Instructions).............................................................................................................................. | PF |
5. | Check if Disclosure or Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e).......................................... | £ |
6. | Citizenship or Place of Organization.............................................................................................................................. | United States |
7. | Sole Voting Power | 63,000 | ||
Number of | ||||
Shares | 209,500 | |||
Beneficially | 8. | Shared Voting Power | ||
Owned by | ||||
Each | ||||
Reporting | 9. | Sole Dispositive Power | 63,000 | |
Person | ||||
With | 10. | Shared Dispositive Power | 209,500 | |
11. | Aggregate Amount Beneficially Owned by Each Reporting Person........................................................................ | 272,500* |
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)................................... | o |
13. | Percent of Class Represented by Amount in Row (11)............................................................................................... | 4.7%** |
14. | Type of Reporting Person (See Instructions) | IN |
CUSIP No. | 007586100 |
1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). | |
Camden Real Estate Company | ||
58-1913586 |
2. | Check the Appropriate Box if a Member of a Group (See Instructions) |
(a) | ............................................................................................................................................................................................ | ü | |
(b) | ............................................................................................................................................................................................ | £ |
3. | SEC Use Only ................................................................................................................................................................... |
4. | Source of Funds (See Instructions).............................................................................................................................. | WC |
5. | Check if Disclosure or Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e).......................................... | £ |
6. | Citizenship or Place of Organization ............................................................................................................................. | GA |
7. | Sole Voting Power | 30,000 | ||
Number of | ||||
Shares | 209,500 | |||
Beneficially | 8. | Shared Voting Power | ||
Owned by | ||||
Each | ||||
Reporting | 9. | Sole Dispositive Power | 30,000 | |
Person | ||||
With | 10. | Shared Dispositive Power | 209,500 | |
11. | Aggregate Amount Beneficially Owned by Each Reporting Person........................................................................ | 239,500* |
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)................................... | o |
13. | Percent of Class Represented by Amount in Row (11)............................................................................................... | 4.1%** |
14. | Type of Reporting Person (See Instructions) | CO |
CUSIP No. | 007586100 |
1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). | |
Joseph T. Watters, III |
2. | Check the Appropriate Box if a Member of a Group (See Instructions) |
(a) | ............................................................................................................................................................................................ | ü | |
(b) | ............................................................................................................................................................................................ | £ |
3. | SEC Use Only ................................................................................................................................................................... |
4. | Source of Funds (See Instructions).............................................................................................................................. | PF |
5. | Check if Disclosure or Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e).......................................... | £ |
6. | Citizenship or Place of Organization ............................................................................................................................. | United States |
7. | Sole Voting Power | 163,900 | ||
Number of | ||||
Shares | 209,500 | |||
Beneficially | 8. | Shared Voting Power | ||
Owned by | ||||
Each | ||||
Reporting | 9. | Sole Dispositive Power | 163,900 | |
Person | ||||
With | 10. | Shared Dispositive Power | 209,500 | |
11. | Aggregate Amount Beneficially Owned by Each Reporting Person........................................................................ | 373,400* |
12. | Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)................................... | o |
13. | Percent of Class Represented by Amount in Row (11)............................................................................................... | 6.4%** |
14. | Type of Reporting Person (See Instructions) | IN |
Item 1. | Security and Issuer |
Item 2. | Identity and Background |
a) |
This Schedule 13D/A is being filed on behalf of the following persons (collectively, the “Reporting Persons”):
|
(i) | Covington Health Group, LLC | |
(ii) | John E. McMullan | |
(iii) | John F. McMullan | |
(iv) |
Camden Real Estate Company
|
|
(v) |
Joseph T. Watters, III
|
|
Attached as Exhibit A is a copy of the agreement among the foregoing persons that the Schedule 13D initially filed to report the acquisition that is the subject of this Schedule 13D/A be filed on behalf of each of them.
|
b) |
The address of the principal business offices of each of the Reporting Persons, with the exception of Joseph T. Watters, III, is 1175 Peachtree Street, Suite 1230, Atlanta, GA 30361. The address of the principal business offices of Joseph T. Watters, III is P.O. Box 470, Adairsville, GA 30103.
|
|
c) |
Covington Health Group, LLC is a Delaware limited liability company engaged in the business of investments. Camden Real Estate Company is a Georgia investment company. The principal occupation of John E. McMullan and John F. McMullan is the operation of senior living communities, and the principal occupation of Joseph T. Watters, III, is whole sale manufacturing.
|
|
d) |
None.
|
|
e) |
None.
|
|
f) |
Citizenship:
|
(i) | Covington Health Group, LLC, a Delaware limited liability company | |
(ii) | John E. McMullan: United States | |
(iii) | John F. McMullan: United States | |
(iv) |
Camden Real Estate Company, a Georgia corporation
|
|
(v) |
Joseph T. Watters, III: United States
|
Item 3. | Source and Amount of Funds or Other Consideration |
Item 4. | Purpose of Transaction |
Item 5. | Interest in Securities of the Issuer |
|
(a)
|
See pages 2 – 6 of cover pages. The Reporting Persons together as a group own 583,560 shares of the Issuer’s common stock, which constitutes 10.0% of the Issuer’s common stock.
|
(b) | See pages 2 - 6 of cover pages. |
|
(c)
|
Transactions in the Issuer’s securities in the last 60 days:
|
|
Reporting Person: Covington Health Group, LLC
|
|
- On August 4, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
100 shares at $5.50 per share
|
·
|
400 shares at $5.50 per share
|
·
|
1,500 shares at $5.5992 per share
|
·
|
400 shares at $5.60 per share
|
·
|
140 shares at $5.60 per share
|
·
|
160 shares at $5.60 per share
|
·
|
600 shares at $5.49833 per share
|
·
|
560 shares at $5.5999 per share
|
·
|
3,440 shares at $5.60 per share
|
|
- On August 2, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
760 shares at $5.80 per share
|
·
|
240 shares at $5.80 per share
|
·
|
400 shares at $5.80 per share
|
·
|
100 shares at $5.80 per share
|
·
|
100 shares at $5.80 per share
|
·
|
100 shares at $5.80 per share
|
·
|
200 shares at $5.80 per share
|
·
|
200 shares at $5.80 per share
|
·
|
100 shares at $5.80 per share
|
·
|
194 shares at $6.00 per share
|
·
|
1,000 shares at $5.95 per share
|
·
|
2,200 shares at $5.94955 per share
|
·
|
800 shares at $5.94 per share
|
·
|
500 shares at $5.96 per share
|
·
|
1,300 shares at $5.95462
|
·
|
200 shares at $5.92 per share
|
|
- On August 1, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
5,000 shares at $5.90 per share
|
·
|
380 shares at $5.90 per share
|
·
|
420 shares at $5.90 per share
|
·
|
200 shares at $5.90 per share
|
·
|
880 shares at $5.90 per share
|
·
|
100 shares at $5.90 per share
|
·
|
500 shares at $5.90 per share
|
·
|
120 shares at $5.90 per share
|
·
|
100 shares at $5.90 per share
|
·
|
200 shares at $5.90 per share
|
·
|
2,100 shares at $5.90 per share
|
·
|
1,200 shares at $5.9993 per share
|
·
|
100 shares at $6.15 per share
|
·
|
500 shares at $6.15 per share
|
·
|
500 shares at $6.15 per share
|
·
|
3,000 shares at $6.25 per share
|
·
|
1,099 shares at $6.25 per share
|
·
|
1,000 shares at $6.25 per share
|
·
|
800 shares at $6.25 per share
|
·
|
1,300 shares at $6.25 per share
|
·
|
401 shares at $6.25 per share
|
·
|
1,300 shares at $6.25 per share
|
·
|
600 shares at $6.25 per share
|
·
|
500 shares at $6.25 per share
|
|
- On July 29, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
100 shares at $6.48 per share
|
·
|
100 shares at $6.48 per share
|
·
|
100 shares at $6.48 per share
|
·
|
200 shares at $6.48 per share
|
·
|
100 shares at $6.48 per share
|
·
|
2,500 shares at $6.50 per share
|
·
|
1,750 shares at $6.50 per share
|
·
|
1,572 shares at $6.50 per share
|
·
|
78 shares at $6.50 per share
|
·
|
100 shares at $6.51 per share
|
·
|
100 shares at $6.51 per share
|
·
|
1,000 shares at $6.51 per share
|
·
|
500 shares at $6.48 per share
|
·
|
800 shares at $6.51 per share
|
|
- On July 25, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
300 shares at $6.7899 per share
|
|
- On July 22, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
1,000 shares at $6.86 per share
|
·
|
600 shares at $6.86 per share
|
·
|
300 shares at $6.86 per share
|
·
|
300 shares at $6.86 per share
|
·
|
1,100 shares at $6.86 per share
|
·
|
67 shares at $6.90 per share
|
·
|
100 shares at $6.90 per share
|
·
|
300 shares at $6.90 per share
|
·
|
300 shares at $6.90 per share
|
·
|
333 shares at $6.90 per share
|
·
|
100 shares at $6.90 per share
|
|
- On July 20, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
200 shares at $6.895 per share
|
|
- On July 19, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
483 shares at $6.95 per share
|
·
|
620 shares at $6.9499 per share
|
·
|
1,480 shares at $6.95 per share
|
·
|
2,100 shares at $6.9499 per share
|
|
- On July 11, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
600 shares at $6.88
|
·
|
400 shares at $6.88
|
·
|
1,000 shares at $6.8793
|
|
- On July 8, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
200 shares at $6.90
|
·
|
2,000 shares at $6.90
|
·
|
400 shares at $6.89
|
·
|
164 shares at $6.89
|
·
|
5,000 shares at $6.90
|
·
|
100 shares at $6.80
|
·
|
100 shares at $6.80
|
·
|
404 shares at $6.90
|
·
|
1,100 shares at $6.89
|
·
|
3,496 shares at $6.8972
|
·
|
100 shares at $6.80
|
·
|
1,500 shares at $6.8293
|
|
- On July 6, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
200 shares at $6.91
|
·
|
500 shares at $6.90
|
·
|
800 shares at $6.90
|
·
|
1,500 shares at $6.8993
|
·
|
700 shares at $6.85
|
|
- On June 30, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
200 shares at $6.85
|
·
|
200 shares at $6.85
|
·
|
500 shares at $6.85
|
·
|
200 shares at $6.85
|
·
|
200 shares at $6.85
|
·
|
800 shares at $6.85
|
·
|
200 shares at $6.85
|
|
- On June 28, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
700 shares at $6.80
|
·
|
300 shares at $6.80
|
·
|
300 shares at $6.80
|
·
|
140 shares at $6.80
|
·
|
201 shares at $6.80
|
·
|
299 shares at $6.80
|
·
|
901 shares at $6.80
|
|
- On June 24, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
100 shares at $6.85
|
·
|
500 shares at $6.85
|
·
|
100 shares at $6.85
|
·
|
300 shares at $6.85
|
·
|
200 shares at $6.85
|
·
|
1,000 shares at $6.85
|
|
- On June 22, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
96 shares at $6.94
|
·
|
600 shares at $6.94
|
·
|
3,804 shares at $6.94
|
|
- On June 15, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
100 shares at $6.67
|
·
|
3,115 shares at $6.69
|
·
|
200 shares at $6.69
|
·
|
896 shares at $6.68
|
·
|
4 shares at $6.68
|
|
- On June 14, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
39 shares at $6.745
|
·
|
1 share at $6.75
|
·
|
100 shares at $6.75
|
·
|
400 shares at $6.75
|
·
|
500 shares at $6.75
|
·
|
200 shares at $6.75
|
·
|
960 shares at $6.74
|
·
|
300 shares at $6.73
|
·
|
2,500 shares at $6.73
|
|
- On June 10, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
79 shares at $6.70
|
·
|
100 shares at $6.70
|
·
|
621 shares at $6.70
|
·
|
1,000 shares at $6.7991
|
|
- On June 9, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
100 shares at $6.70
|
·
|
100 shares at $6.70
|
|
- On June 8, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
300 shares at $6.70
|
·
|
1,200 shares at $6.70
|
·
|
800 shares at $6.75
|
|
- On June 6, 2011, Covington Health Group, LLC purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
100 shares at $6.70
|
·
|
161 shares at $6.67
|
|
Reporting Person: John E. McMullan
|
|
- On August 5, 2011, John E. McMullan purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
200 shares at $5.91 per share
|
·
|
10 shares at $6.00 per share
|
·
|
300 shares at $6.00 per share
|
·
|
200 shares at $6.00 per share
|
·
|
200 shares at $6.00 per share
|
·
|
300 shares at $6.00 per share
|
·
|
100 shares at $6.00 per share
|
·
|
100 shares at $5.82 per share
|
·
|
100 shares at $5.78 per share
|
·
|
100 shares at $6.00 per share
|
·
|
10,000 shares at $6.00 per share
|
·
|
450 shares at $5.85 per share
|
·
|
100 shares at $5.82 per share
|
·
|
10,000 shares at $6.00 per share
|
|
- On August 4, 2011, John E. McMullan purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
400 shares at $5.28 per share
|
·
|
200 shares at $5.36 per share
|
·
|
100 shares at $5.36 per share
|
·
|
100 shares at $5.39 per share
|
·
|
20 shares at $5.40 per share
|
·
|
700 shares at $5.40 per share
|
·
|
100 shares at $5.48 per share
|
·
|
300 shares at $5.49 per share
|
·
|
100 shares at $5.49 per share
|
·
|
100 shares at $5.49 per share
|
·
|
100 shares at $5.50 per share
|
·
|
200 shares at $5.50 per share
|
·
|
200 shares at $5.50 per share
|
·
|
200 shares at $5.50 per share
|
·
|
200 shares at $5.50 per share
|
·
|
200 shares at $5.50 per share
|
·
|
200 shares at $5.50 per share
|
·
|
300 shares at $5.50 per share
|
·
|
500 shares at $5.50 per share
|
·
|
200 shares at $5.50 per share
|
·
|
300 shares at $5.50 per share
|
·
|
200 shares at $5.50 per share
|
·
|
100 shares at $5.51 per share
|
·
|
100 shares at $5.51 per share
|
·
|
100 shares at $5.51 per share
|
·
|
100 shares at $5.51 per share
|
·
|
100 shares at $5.51 per share
|
·
|
100 shares at $5.51 per share
|
·
|
100 shares at $5.56 per share
|
·
|
100 shares at $5.57 per share
|
·
|
100 shares at $5.57 per share
|
·
|
100 shares at $5.57 per share
|
·
|
100 shares at $5.57 per share
|
·
|
200 shares at $5.58 per share
|
·
|
2,200 shares at $5.60 per share
|
·
|
100 shares at $5.60 per share
|
·
|
100 shares at $5.60 per share
|
·
|
100 shares at $5.60 per share
|
·
|
100 shares at $5.60 per share
|
·
|
100 shares at $5.60 per share
|
·
|
100 shares at $5.60 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
100 shares at $5.61 per share
|
·
|
1,000 shares at $5.625 per share
|
·
|
1,100 shares at $5.625 per share
|
·
|
200 shares at $5.65 per share
|
·
|
100 shares at $5.65 per share
|
·
|
100 shares at $5.79 per share
|
·
|
1,100 shares at $5.80 per share
|
·
|
100 shares at $5.80 per share
|
·
|
100 shares at $5.80 per share
|
·
|
100 shares at $5.80 per share
|
·
|
480 shares at $5.80 per share
|
|
- On August 2, 2011, John E. McMullan purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
25,000 shares at $6.00 per share
|
|
- On August 1, 2011, John E. McMullan purchased the following number of shares at the following prices per share, all in open market transactions:
|
·
|
30,000 shares at $6.00 per share
|
(d)
|
N/A
|
|
(e) | N/A |
Item 6. | Contracts, Arrangements, Understandings or Relationships with Respect to the Securities of the Issuer |
Item 7. | Materials to be Filed as Exhibits |
Exhibit A. | Joint Filing Agreement |
Exhibit B. | Power of Attorney |
Exhibit C. | Power of Attorney |
Exhibit D. | Power of Attorney |
COVINGTON HEALTH GROUP, LLC |
By: | /s/ John E. McMullan* |
Name: John E. McMullan | |
Title: Manager |
|
CAMDEN REAL ESTATE COMPANY |
By: | /s/ John F. McMullan** |
Name: John F. McMullan | |
Title: Presiden |
/s/ John E. McMullan* | ||
John E. McMullan |
/s/ John F. McMullan** | ||
John F. McMullan |
/s/ Joseph T. Watters, III*** | ||
Joseph T. Watters, III |
* | By Attorney-in-Fact, pursuant to Power of Attorney attached to this Schedule 13D/A as Exhibit B. |
** | By Attorney-in-Fact, pursuant to Power of Attorney attached to this Schedule 13D/A as Exhibit C. |
*** | By Attorney-in-Fact, pursuant to Power of Attorney attached to this Schedule 13D/A as Exhibit D. |
COVINGTON HEALTH GROUP, LLC |
By: | /s/ John E. McMullan |
Name: John E. McMullan | |
Title: Manager |
|
CAMDEN REAL ESTATE COMPANY |
By: | /s/ John F. McMullan |
Name: John F. McMullan | |
Title: Presiden |
/s/ John E. McMullan | ||
John E. McMullan |
/s/ John F. McMullan | ||
John F. McMullan |
/s/ Joseph T. Watters, III | ||
Joseph T. Watters, III |
1.
|
execute for and on behalf of the undersigned, in the undersigned's individual capacity and in the undersigned’s capacity as manager of Covington Health Group, LLC (the “Company”), a Schedule 13D and any and all amendments thereto, and a Joint Filing Agreement in connection therewith, with respect to the undersigned’s and the Company's holdings of and transactions in securities issued by Advocat, Inc., in accordance with Section 13(d) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder;
|
2.
|
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule 13D, complete and execute any amendment or amendments thereto, execute a Joint Filing Agreement in connection therewith, and timely file such schedule and agreement with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
|
3.
|
take any and all other actions of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
|
1.
|
execute for and on behalf of the undersigned, in the undersigned’s individual capacity and in the undersigned's capacity as President of Camden Real Estate Company (the “Company”), a Schedule 13D and any and all amendments thereto, and a Joint Filing Agreement in connection therewith, with respect to the undersigned’s and the Company's holdings of and transactions in securities issued by Advocat, Inc., in accordance with Section 13(d) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder;
|
2.
|
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule 13D, complete and execute any amendment or amendments thereto, execute a Joint Filing Agreement in connection therewith, and timely file such schedule and agreement with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
|
3.
|
take any and all other actions of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
|
1.
|
execute for and on behalf of the undersigned a Schedule 13D and any and all amendments thereto, and a Joint Filing Agreement in connection therewith, with respect to the undersigned’s holdings of and transactions in securities issued by Advocat, Inc., in accordance with Section 13(d) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder;
|
2.
|
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Schedule 13D, complete and execute any amendment or amendments thereto, execute a Joint Filing Agreement in connection therewith, and timely file such schedule and agreement with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
|
3.
|
take any and all other actions of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
|